1. Home
  2. STM vs WAT Comparison

STM vs WAT Comparison

Compare STM & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STMicroelectronics N.V.

STM

STMicroelectronics N.V.

HOLD

Current Price

$25.98

Market Cap

28.2B

Sector

Technology

ML Signal

HOLD

Logo Waters Corporation

WAT

Waters Corporation

HOLD

Current Price

$383.45

Market Cap

23.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STM
WAT
Founded
1987
1958
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.2B
23.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
STM
WAT
Price
$25.98
$383.45
Analyst Decision
Buy
Buy
Analyst Count
7
15
Target Price
$32.60
$388.67
AVG Volume (30 Days)
6.0M
544.8K
Earning Date
01-29-2026
11-04-2025
Dividend Yield
1.18%
N/A
EPS Growth
N/A
3.82
EPS
0.58
10.88
Revenue
$11,792,000,000.00
$3,105,638,000.00
Revenue This Year
N/A
$7.96
Revenue Next Year
$10.76
$6.32
P/E Ratio
$43.46
$35.43
Revenue Growth
N/A
6.90
52 Week Low
$17.25
$275.05
52 Week High
$33.47
$423.56

Technical Indicators

Market Signals
Indicator
STM
WAT
Relative Strength Index (RSI) 60.99 50.66
Support Level $25.79 $385.08
Resistance Level $26.41 $397.55
Average True Range (ATR) 0.53 9.42
MACD 0.43 -3.19
Stochastic Oscillator 86.71 7.46

Price Performance

Historical Comparison
STM
WAT

About STM STMicroelectronics N.V.

A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

Share on Social Networks: